Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impax Rytary FDA Action Date Extended by Three Months
Yahoo/Zacks.com
Thursday, September 18, 2014 - 7:37pm
tags:
Impax, Rytary, FDA, IPX066
Bayer Deal for Zoetis in Sight After Unit Sale: Real M&A
Bloomberg
Thursday, September 18, 2014 - 7:30pm
tags:
Bayer, Zoetis, animal health
FDA Approves Lilly's Once-Weekly Shot For Diabetes
Forbes
Thursday, September 18, 2014 - 7:28pm
tags:
FDA, Eli Lilly, diabetes, Trulicity, dulaglutide
Gilead Sciences: Failed Trial Always a ‘Long Shot’
Barron's
Thursday, September 18, 2014 - 12:03pm
tags:
Gilead Sciences, clinical trials, pancreatic cancer, simtuzumab
Dealpolitik: Allergan Fight Could Extend Long Past December Meeting
WSJ Online
Thursday, September 18, 2014 - 10:29am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Fierce Biotech
Thursday, September 18, 2014 - 9:57am
tags:
Boehringer Ingelheim, vaccines, CureVac, lung cancer, CV9202
Protein Sciences nabs stake in diabetes vax developer Diamyd
Fierce Vaccines
Thursday, September 18, 2014 - 9:55am
tags:
Protein Sciences, Diamyd Medical, diabetes, vaccines
FDA OKs 1st glucose meter with insulin calculator
Mass Device
Thursday, September 18, 2014 - 9:33am
tags:
FDA, glucose meters, insulin calculator, diabetes, devices, Roche, Accu-Chek Aviva Expert
Cubist extends superbug R&D to Europe
Pharmaphorum
Thursday, September 18, 2014 - 9:27am
tags:
Cubist Pharmaceuticals, Europe, R&D, antibiotics, antibiotic resistance
Flexion tanks as FDA clamps a hold on its lead osteoarthritis drug
Fierce Biotech
Thursday, September 18, 2014 - 9:25am
tags:
FDA, Flexion, osteoarthritis of the knee, FX0006
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Fierce Biotech
Thursday, September 18, 2014 - 9:24am
tags:
Merck, diabetes, Januvia, omarigliptin, MK-3102
Are obesity drugs nearing a breakout? Novo, Takeda think so
Fierce Pharma
Thursday, September 18, 2014 - 9:18am
tags:
Novo Nordisk, Takeda, obesity, Saxenda
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Yahoo/Zacks.com
Thursday, September 18, 2014 - 9:17am
tags:
Amgen, UCB Pharmaceuticals, romosozumab, low bone mineral density
Faster-acting erectile dysfunction drug gets FDA approval
Yahoo/Reuters
Thursday, September 18, 2014 - 9:13am
tags:
FDA, erectile dysfunction, Vivus, Auxilium, Stendra
Auxilium Mulls Endo Bid; Is $2.2 Billion Enough?
Investors.com
Thursday, September 18, 2014 - 9:07am
tags:
Auxilium, Endo Health Solutions, M&A
Ranbaxy Faces Medicaid Pricing Probe by the Justice Department
WSJ Pharmalot
Thursday, September 18, 2014 - 9:01am
tags:
Ranbaxy, Medicaid, DOJ
GSK melanoma pill backed by UK cost watchdog with price cut
Yahoo/Reuters
Thursday, September 18, 2014 - 8:59am
tags:
GSK, UK, melanoma, Tafinlar
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
Yahoo/AP
Thursday, September 18, 2014 - 8:57am
tags:
FDA, advisory panels, testosterone, AbbVie, Eli Lilly
Merck KGaA seeks partner for immuno-oncology drug by year-end
Yahoo/Reuters
Thursday, September 18, 2014 - 8:55am
tags:
Merck KGaA, immuno-oncology, anti-PD-L1
Sanofi, MannKind say cutting insulin costs will make Afrezza more competitive
Fierce Pharma Marketing
Wednesday, September 17, 2014 - 5:47pm
tags:
Sanofi, MannKind, insulin, diabetes, Afrezza

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.